It is indisputable that patients with CVD exhibit platelets with a hyperactive phenotype characterized by higher aggregation, activation, and adhesion (184)
This makes it an ideal solution for those seeking rapid and effective weight loss
Notably, research indicates that individuals most interested in trying GLP-1 medications, and willing to accept common side effects, are those who report greater body shame, body surveillance, weight concerns, anti-fat bias, disordered eating behaviors, and higher BMIs, alongside lower body appreciation and body neutrality (Markey et al., 2025)
The rising interest towards glutathiones pharmaceutical use should bolster the glutathione market in the coming years